Venture capital has adjusted its posture. After several years of excess liquidity followed by a sharp correction, the industry has entered a more disciplined phase. Capital remains available across stages, but deployment decisions are more deliberate, thesis-driven, and grounded in measurable performance indicators.
In practical terms, investors are concentrating capital behind clearer sector convictions, stronger unit economics, and demonstrable paths to profitability. The emphasis has shifted from growth at any cost to sustainable value creation. Against this backdrop, several structural trends are shaping fundraising dynamics in 2026.
Sustainability has moved from branding to underwriting. Over one-third of global assets under management – more than $30 trillion – are now screened for ESG factors. In Europe, ESG-aligned funds continue to capture a disproportionate share of institutional allocations.
For founders, this means ESG must be operationalised, not narrated. Carbon intensity, governance structure, and supply-chain transparency increasingly influence valuation and due diligence outcomes.
AI captured roughly 35–40% of global VC funding in 2025, with generative AI and enterprise automation leading the way. However, the funding gap between top-quartile AI startups and the rest is widening. Investors are no longer backing ‘AI-enabled’ decks. They are backing proprietary data, defensible distribution, and measurable efficiency gains.
Global digital health investment has stabilised after its post-pandemic correction, yet biotech and platform-based therapeutics continue to attract long-term capital. Ageing populations and rising healthcare costs create durable demand.
The bar, however, is higher: clinical milestones, regulatory pathways, and reimbursement logic must be visible early.
Capital concentration risk is now a board-level concern for many funds. Investors are allocating more deliberately across regions – including the Middle East, Southeast Asia, and selected emerging European ecosystems – to balance US-centric exposure. Founders outside traditional hubs may find opportunity in this shift, provided governance and reporting standards meet global expectations.
Question: If capital is still being deployed at scale, why are so many startups struggling to raise? The answer is uncomfortable: capital has not disappeared but undifferentiated companies have.
At Notable Investors, we continue to deploy capital across ESG, fintech, and technology infrastructure projects, with a clear bias toward scalability, governance discipline, and measurable impact.
If you are raising in 2026, the question is not whether your sector is ‘hot’. It is whether your company is structurally investable.
